Dried blood spots (DBS) on filter paper are widely used for serological diagnosis because they require minimal blood volumes and enable storage and transport without refrigeration, making them particularly useful in remote and resource-limited settings. However, DBS-based serology may be compromised by methodological variability and the lack of standardized preservation protocols. We evaluated the effects of preservation factors and quality indicators on DBS serological performance for Toxoplasma gondii, a pathogen with a broad host range and limited seasonal variability. We analyzed 787 dB samples from 17 mammal species collected by subsistence hunters in an Indigenous community in the northern Peruvian Amazon between 2008 and 2020. Recorded variables included filter paper type, time to cold-chain initiation, time to analysis, blood saturation, fungal contamination, and colorimetric values of reconstituted blood. Linear models with Type II ANOVA and AIC-based model selection were used to identify factors associated with seropositivity. Filter paper type was the primary determinant of serological outcomes, while severe fungal contamination was associated with reduced seropositivity. Colorimetric values were significantly related to serological results and may serve as a simple indicator of sample quality. These findings highlight the importance of standardized preservation protocols to minimize false negatives under tropical conditions. DBS-based serological studies should prioritize Protein Saver cards, limit fungal growth, and incorporate basic quality assessments to improve the reliability of wildlife disease surveillance within a One Health framework.
Visceral leishmaniasis (VL) caused by Leishmania infantum remains a major public health concern in endemic regions and has shown geographic expansion in recent decades. Accurate and accessible diagnostics are essential for detecting infection in canine reservoirs that sustain transmission. Loop-mediated isothermal amplification (LAMP) represents a promising alternative to PCR-based techniques, combining diagnostic accuracy with lower cost and operational simplicity. Five LAMP assays targeting kinetoplast DNA (kDNA), internal transcribed spacers (ITS1 and ITS2), and the K26 gene were evaluated and compared with nested PCR targeting ITS1 (nPCR-ITS1). Most assays demonstrated species-level specificity for L. infantum, with the exception of the ITS2-targeting assay, which showed cross-amplification with Leishmania amazonensis. The kDNA-, ITS1-, and K26-targeting assays showed analytical sensitivity comparable to or higher than nPCR-ITS1. Considering its analytical performance and shared molecular target with the reference method, the ITS1-targeting assay (LAMP-P34) was selected for field evaluation. In canine samples from endemic and non-endemic areas, LAMP-P34 showed 80.4% sensitivity (37/46) and 100% specificity (0/58), using a reference panel based on nPCR-ITS1 positivity in lymph node or bone marrow samples to define infection and combined negative serology and molecular results to define non-infected dogs. Agreement with nPCR-ITS1 was almost perfect (κ = 0.887; 116/122, 95.1%). The high concordance with nPCR-ITS1 together with a simplified workflow underscores the potential of LAMP-P34 to expand access to molecular diagnosis and strengthen surveillance and control strategies in endemic areas.

